mifepristone has been researched along with Psychotic Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golier, JA; Yehuda, R | 1 |
| Howland, RH | 1 |
| Schatzberg, AF | 1 |
| Bendall, S; Garner, B; Hetrick, SE; Phillips, LJ | 1 |
| Belanoff, JK; Blasey, CM; Block, T; Debattista, C; Roe, R | 1 |
| Belanoff, JK; Blasey, CM; Block, TS; Roe, RL | 1 |
| Hui, X; Wang, MW; Zhou, CH | 1 |
| Alva, G; Belanoff, J; Blasey, C; Carpenter, LL; DeBattista, C; Glass, S; Horne, RL; Khan, A | 1 |
| Nihalani, ND; Schwartz, TL | 1 |
| de Graaff, M; Dirks, A; Groenink, L; Millan, MJ; Olivier, B; Peeters, BW; Verdouw, PM | 1 |
| Carroll, BJ; Rubin, RT | 1 |
| Bilgin, YM; De Herder, WW; Fischer, HR; van der Wiel, HE | 1 |
| Belanoff, JK; Flores, BH; Kalezhan, M; Schatzberg, AF; Sund, B | 1 |
| Foeken, K; Lamberts, SW; van der Lely, AJ; van der Mast, RC | 1 |
5 review(s) available for mifepristone and Psychotic Disorders
| Article | Year |
|---|---|
Mifepristone as a therapeutic agent in psychiatry.
Topics: Affective Disorders, Psychotic; Alcoholism; Antipsychotic Agents; Clinical Trials as Topic; Cocaine-Related Disorders; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mental Disorders; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Stress Disorders, Post-Traumatic; Weight Gain | 2013 |
Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
Topics: Awards and Prizes; Clinical Trials as Topic; Cognition Disorders; Depressive Disorder, Major; Dexamethasone; Dopamine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid | 2015 |
Antiglucocorticoid and related treatments for psychosis.
Topics: Dehydroepiandrosterone; Dexamethasone; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Ketoconazole; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Randomized Controlled Trials as Topic | 2016 |
Glucocorticoid receptor and treatment of psychotic major depression.
Topics: Animals; Brain; Dehydroepiandrosterone; Depressive Disorder, Major; Humans; Metyrapone; Mifepristone; Psychotic Disorders; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid | 2005 |
Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression.
Topics: Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Depressive Disorder, Major; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Psychotic Disorders | 2007 |
4 trial(s) available for mifepristone and Psychotic Disorders
| Article | Year |
|---|---|
A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.
Topics: Adult; Antidepressive Agents; Brief Psychiatric Rating Scale; Comorbidity; Depression; Drug Administration Routes; Humans; Mifepristone; Psychotic Disorders; Receptors, Glucocorticoid | 2009 |
Efficacy and safety of mifepristone for the treatment of psychotic depression.
Topics: Adult; Depressive Disorder; Dizziness; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Mifepristone; Psychotic Disorders; Treatment Outcome | 2011 |
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
Topics: Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Hormone Antagonists; Humans; Male; Middle Aged; Mifepristone; Psychiatric Status Rating Scales; Psychotic Disorders | 2006 |
Rapid reversal of psychotic depression using mifepristone.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Brief Psychiatric Rating Scale; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Hormone Antagonists; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Psychotic Disorders; Time Factors | 2001 |
6 other study(ies) available for mifepristone and Psychotic Disorders
| Article | Year |
|---|---|
Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Humans; Mifepristone; Psychotic Disorders | 2018 |
New treatments for depression with psychosis. Two experimental treatments for depression have shown promise in preliminary studies; one a relatively new drug, the other a familiar hormone.
Topics: Antipsychotic Agents; Depression; Humans; Male; Mifepristone; Psychotic Disorders; Testosterone | 2003 |
CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF.
Topics: Acoustic Stimulation; Adrenalectomy; Animals; Benzodioxoles; Depressive Disorder, Major; Disease Models, Animal; Gene Expression; Genotype; Hormone Antagonists; Infusions, Parenteral; Male; Mice; Mice, Transgenic; Mifepristone; Psychotic Disorders; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Reflex, Startle; Steroids | 2008 |
Mifepristone in psychotic depression?
Topics: Depressive Disorder, Major; Hormone Antagonists; Humans; Mifepristone; Psychotic Disorders | 2008 |
Treatment of severe psychosis due to ectopic Cushing's syndrome.
Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Drug Therapy, Combination; Etomidate; Female; Hormone Antagonists; Humans; Hydrocortisone; Hypnotics and Sedatives; Lung Neoplasms; Middle Aged; Mifepristone; Psychotic Disorders | 2007 |
Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).
Topics: Acute Disease; Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Female; Glucocorticoids; Humans; Male; Mifepristone; Psychotic Disorders | 1991 |